These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1625525)

  • 21. Tricyclic compounds as selective muscarinic receptor antagonists. 3. Structure-selectivity relationships in a series of cardioselective (M2) antimuscarinics.
    Engel WW; Eberlein WG; Mihm G; Hammer R; Trummlitz G
    J Med Chem; 1989 Aug; 32(8):1718-24. PubMed ID: 2754696
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimuscarinic activity of telenzepine on isolated human urinary bladder: no role for M1-muscarinic receptors.
    Poli E; Monica B; Zappia L; Pozzoli C; Bertaccini G
    Gen Pharmacol; 1992 Jul; 23(4):659-64. PubMed ID: 1397972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional and binding studies with muscarinic M2-subtype selective antagonists.
    Lazareno S; Roberts FF
    Br J Pharmacol; 1989 Sep; 98(1):309-17. PubMed ID: 2804551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of three muscarinic receptor subtypes in rat lung using binding studies with selective antagonists.
    Fryer AD; el-Fakahany EE
    Life Sci; 1990; 47(7):611-8. PubMed ID: 2402185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Telenzepine enantiomers block muscarinic M1-receptors with opposite kinetics.
    Eltze M
    Eur J Pharmacol; 1990 May; 180(1):161-8. PubMed ID: 2365000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. M2 muscarinic receptor-mediated inhibition of the Ca2+ current in rat magnocellular cholinergic basal forebrain neurones.
    Allen TG; Brown DA
    J Physiol; 1993 Jul; 466():173-89. PubMed ID: 8410690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of agonists and selective antagonists with gastric smooth muscle muscarinic receptors.
    Lucchesi PA; Romano FD; Scheid CR; Yamaguchi H; Honeyman TW
    Naunyn Schmiedebergs Arch Pharmacol; 1989; 339(1-2):145-51. PubMed ID: 2498669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of muscarinic receptors in dog tracheal smooth muscle cells.
    Yang CM
    J Auton Pharmacol; 1991 Feb; 11(1):51-61. PubMed ID: 2030109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular probes for muscarinic receptors: functionalized congeners of selective muscarinic antagonists.
    Jacobson KA; Fischer B; van Rhee AM
    Life Sci; 1995; 56(11-12):823-30. PubMed ID: 10188781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coupling of subtypes of the muscarinic receptor to adenylate cyclase in the corpus striatum and heart.
    Ehlert FJ; Delen FM; Yun SH; Friedman DJ; Self DW
    J Pharmacol Exp Ther; 1989 Nov; 251(2):660-71. PubMed ID: 2810116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and biological evaluation of phenylacetyl derivatives having low central nervous system permeability as potent and selective M2 muscarinic receptor antagonists.
    Watanabe T; Kakefuda A; Tanaka A; Takizawa K; Hirano S; Shibata H; Yamagiwa Y; Yanagisawa I
    Chem Pharm Bull (Tokyo); 1998 Jan; 46(1):53-68. PubMed ID: 9468637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of muscarinic M4 binding sites in rabbit lung, chicken heart, and NG108-15 cells.
    Lazareno S; Buckley NJ; Roberts FF
    Mol Pharmacol; 1990 Dec; 38(6):805-15. PubMed ID: 2250662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of phosphoinositide turnover by selective muscarinic antagonists in the rat striatum. Correlation with receptor occupancy.
    Monsma FJ; Abood LG; Hoss W
    Biochem Pharmacol; 1988 Jun; 37(12):2437-43. PubMed ID: 2839194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-[3H]methylscopolamine labeling of non-M1, non-M2 muscarinic receptor binding sites in rat brain.
    Smith TD; Annis SJ; Ehlert FJ; Leslie FM
    J Pharmacol Exp Ther; 1991 Mar; 256(3):1173-81. PubMed ID: 2005579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The putative M1 muscarinic receptor does not regulate phosphoinositide hydrolysis. Studies with pirenzepine and McN-A343 in chick heart and astrocytoma cells.
    Brown JH; Goldstein D; Masters SB
    Mol Pharmacol; 1985 May; 27(5):525-31. PubMed ID: 2581122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological characterization of muscarine receptors of PC12 (rat phaeochromocytoma) cells.
    Bönisch H; Boer R; Dobler M; Schudt C
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Mar; 341(3):158-64. PubMed ID: 2342599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological evidence for selective inhibition of gastric acid secretion by telenzepine, a new antimuscarinic drug.
    Eltze M; Gönne S; Riedel R; Schlotke B; Schudt C; Simon WA
    Eur J Pharmacol; 1985 Jun; 112(2):211-24. PubMed ID: 4029260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological differentiation of presynaptic M1 muscarinic receptors modulating acetylcholine release from postsynaptic muscarinic receptors in guinea-pig ileum.
    Kawashima K; Fujimoto K; Suzuki T; Oohata H
    Gen Pharmacol; 1990; 21(1):17-21. PubMed ID: 2298386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective agents for muscarinic receptors linked to phosphoinositide breakdown.
    Noronha-Blob L; Canning B; Costello D; Kinnier WJ
    Eur J Pharmacol; 1988 Sep; 154(2):161-7. PubMed ID: 2852597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does the prolonged occupancy of M1 receptors by telenzepine protect them against the action of vagally released acetylcholine?
    Schudt C; Auriga C; Birdsall NJ; Boer R
    Pharmacology; 1988; 37 Suppl 1():32-9. PubMed ID: 3237765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.